openPR Logo
Press release

Allogenic Cell Therapies Market Exclusive Report on the Latest Revenue and Future Scope

Allogenic Cell Therapies Market Exclusive Report on the Latest

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allogenic Cell Therapies Market- by Cell Type(Cardiosphere-Derived Cells (CDCs), Fibroblasts, T-cells, Mesenchymal Stem Cells (MSCs), Hematopoietic Stem Cells (HSCs) and Others),Tissue Source(Skin, Blood, PBC, BM and Others), Indication (Acute graft-versus-host disease (GVHD), Chronic Ulcers and Diabetic Foot Ulcers, Osteoarthritis, Crohn's Disease, Cardiovascular Disease, Solid Tumors/Cancers and Others (Alzheimer's Disease, etc.)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the globalAllogenic Allogeneic Cell Therapy Manufacturing Market is expected to grow at a 15.0 % CAGR during the forecast period for 2025-2034.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1194

Allogeneic cell therapy products are demonstrating promising results in both preclinical and clinical studies. This therapeutic approach utilizes healthy cells from unrelated donors, enabling the treatment of multiple patients from a single cell source. During the procedure, a patient receives healthy stem cells from a donor to replace damaged or non-functioning cells. The increasing demand for advanced treatment options for immune disorders, neurodegenerative diseases, and myocardial infarctions has driven growth in allogeneic cell therapy adoption. This surge is reflected in the expansion of stem cell therapy applications, heightened research activity, and increased funding for cell-based medical innovations.

Several factors, such as the rising prevalence of chronic illnesses like cancer, diabetes, and cardiovascular diseases, rising government funding for stem cell therapies, an ageing population, developing healthcare infrastructure, technological advancements, expanding public awareness about the benefits of allogeneic cell therapies, and more are anticipated to drive the demand for the allogeneic cell therapy manufacturing market during the forecast period. Allogeneic cell therapies are being introduced by numerous pharmaceutical companies to treat patients with chronic illnesses. In response to the growing need for low-cost and efficient cell and gene therapies, outsourcing contract research organisations (CROs) have boosted bioassay services, enhancing market growth prospects in the near future.

Allogeneic cell therapy manufacturing, however, may experience growth restrictions in the upcoming years as a result of high development costs and issues with immunological rejection. North America is anticipated to contribute to the Allogenic Cell Therapies market due to the high prevalence of chronic diseases, increased R&D investments in cell therapy research, and the rapid uptake of cutting-edge technology. In addition, the Asia PacificAllogenic Cell Therapies market is expected to register significant growth. The growing pharmaceutical manufacturing industry in the region, together with rising investments in cell therapy, has played a vital role in the market's growth in the APAC region.

Curious about this latest version of the report?Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1194

Major market players operating in the Allogenic Cell Therapies market include
AtaraBiotherapeutics, ArtivaBiotherapeutic, Adaptimmune Therapeutics plc, Adicet Bio, Inc., Allogene Therapeutics, Athersys, Inc., BioCardia Inc., Bluebird Bio, BlueRock Therapeutics LP, Bone Therapeutics, Celyad, Capricor Therapeutics, Cellectis, Cyto Therapeutics Pty Limited, Cynata Therapeutics, Century Therapeutics, GammaDelta Therapeutics Limited, Fate Therapeutics, Osiris Therapeutics, Inc., Organogenesis Inc., Mesoblast Ltd, MEDIPOST, Nkarta, Inc., NantKwest, Pluristem Therapeutics Inc, Regeneus, Lineage Cell Therapeutics, Inc., Stempeutics, Stemedica Cell Technologies, Inc., TiGenix (Takeda) and TCR2 Therapeutics.

Recent collaborations and agreements in the market:
• In January 2022,Rexlemestrocel-L (MPC-06-ID), an allogeneic cell therapy, was tested in a Phase 3 trial on patients with CLBP (chronic low back pain) associated with DDD. Mesoblast Limited (Australi), a global leader in allogeneic cellular medicines for inflammatory diseases, presented the 36-month follow-up results (degenerative disc disease). In this study, a single intra-discal injection of the rexlemestrocel-L+hyaluronic acid (HA) carrier resulted in a significant three-year reduction in back pain.
• In November 2021, a non-binding term sheet for the global rights to ALLOB, the allogeneic bone cell therapy of BONE THERAPEUTICS (Belgium), was signed between Link Health Pharma Co., Ltd. and the cell therapy firm.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1194

Market Segments
Global Allogenic Cell Therapies Market, by Cell Type, 2025-2034 (Value US$ Mn)
• Cardiosphere-Derived Cells (CDCs)
• Fibroblasts
• T-cells
• Mesenchymal Stem Cells (MSCs)
• Hematopoietic Stem Cells (HSCs)
• Others
Global Allogenic Cell Therapies Market, by Tissue Source, 2025-2034 (Value US$ Mn)
• Skin
• Blood
• PBC
• BM
• Others
Global Allogenic Cell Therapies Market, by Indication, 2025-2034 (Value US$ Mn)
• Acute graft-versus-host disease (GVHD)
• Chronic Ulcers and Diabetic Foot Ulcers
• Osteoarthritis
• Crohn's Disease
• Cardiovascular Disease
• Solid Tumors/Cancers
• Others (Alzheimer's Disease, etc.)
Global Allogenic Cell Therapies Market, by Region, 2025-2034 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Allogenic Cell Therapies Market, by Country, 2025-2034 (Value US$ Mn)
• U.S.
• Canada
Europe Allogenic Cell Therapies Market, by Country, 2025-2034 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Allogenic Cell Therapies Market, by Country, 2025-2034 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Allogenic Cell Therapies Market, by Country, 2025-2034 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Allogenic Cell Therapies Market, by Country, 2025-2034 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Get More Informaiton: @
https://www.insightaceanalytic.com/report/global-allogeneic-cell-therapy-manufacturing-market-/1194

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allogenic Cell Therapies Market Exclusive Report on the Latest Revenue and Future Scope here

News-ID: 4292885 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Digital Biomanufacturing Market Regional Analysis Covering North America Europe Asia Pacific Latin America and Middle East Africa
Digital Biomanufacturing Market Regional Analysis Covering North America Europe …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Biomanufacturing Market- by Application (Biomanufacturing Process Automation and Control, Bioprocess Optimization and Process Analytics, and Flexible Manufacturing), End-User (Biopharmaceutical Companies and Academic and Research Institutes), Technology (AI and IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics and Digital Twin Technologies, and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2035." The Digital
Dialysis Equipment Market Trends Shaping the Future of Chronic Kidney Disease Management and Innovative Artificial Kidney Technologies
Dialysis Equipment Market Trends Shaping the Future of Chronic Kidney Disease Ma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Dialysis Equipment Market- by Products (Standard Dialysis Equipment, Portable Device and Wearable Devices), Dialysis Types (Hemodialysis and Peritoneal Dialysis), End-Users (Dialysis Centers, Home Care Settings, Hospitals and Research Laboratories), Trends, Industry Competition Analysis, Revenue and Forecast To 2035." Global Dialysis Equipment Market Size is valued at USD 19.28 Billion in 2025 and is predicted to reach
Clinical Trials Software Market Expansion Fueled by Increasing Government Investment Technological Advancements and Rising Clinical Research Activities
Clinical Trials Software Market Expansion Fueled by Increasing Government Invest …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Software Market- by Type of Deployment (On-cloud and On-premises), Type of Delivery (Web-based and Remote Monitoring), Features of Software (EDC, eCOA/ePRO and eConsent), End-Users (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Medical Device Manufacturers and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2035." Global Clinical Trials Software Market Size is valued
Cellular Health Screening Market Drivers Fueled by Rising Prevalence of Chronic Diseases and Growing Global Elderly Population
Cellular Health Screening Market Drivers Fueled by Rising Prevalence of Chronic …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cellular Health Screening Market By Test (Single Test Panels(Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metals Tests) and Multi-test Panels), Sample Type (Blood, Saliva, Serum and Urine), Collection Site (Home, Office, Hospital and Diagnostic Labs)- Technology Trends, Industry Competition Analysis, Revenue and Forecast Till 2035" Global Cellular Health Screening Market Size is valued at USD 2.62 Bn

All 5 Releases


More Releases for Cell

Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting. Download Full PDF Sample Copy
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging